U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07227194) titled 'Machine Learning Assessment of Next-Day Migraine Likelihood' on Nov. 09.
Brief Summary: Development of a machine learning (ML) algorithm for assessment of next-day migraine likelihood, drawing on self-reported migraine-related information, and geographic location, collected via the Nerivio app- a mobile application used for migraine treatment by the Remote Electrical Neuromodulation (REN) wearable device.
Study Start Date: Feb. 07
Study Type: OBSERVATIONAL
Condition:
Migraine
Recruitment Status: COMPLETED
Sponsor: Theranica
Disclaimer: Curated by HT Syndication....